A phase III randomised, double-blind, active comparator-controlled clinical trial to study the safety and efficacy of lurasidone in subjects with schizophrenia (PEARL 3 extension study)
Keyword(s):
2015 ◽
Vol 72
(5)
◽
pp. AB59
◽
Keyword(s):
2016 ◽
Vol 387
(10037)
◽
pp. 2507-2520
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 40
(2)
◽
pp. 226-241.e4
◽
2001 ◽
Vol 23
(9)
◽
pp. 1446-1455
◽
Keyword(s):
1994 ◽
Vol 30
(4)
◽
pp. 597-602
◽